Navigation Links
Cyberonics to Present at Collins Stewart Fourth Annual Growth Conference
Date:7/7/2008

HOUSTON, July 7 /PRNewswire-FirstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX) today announced that Greg Browne, Chief Financial Officer, will present at the Collins Stewart Fourth Annual Growth Conference in New York City on Wednesday, July 9, 2008 at 1:00 PM EDT. Presentation slides will be available on-line at http://www.cyberonics.com by 8:00 AM EDT on Wednesday, July 9, 2008. Collins Stewart will host a webcast of the presentation live and by replay at http://www.wsw.com/webcast/clst/cybx/. The replay will be available for 90 days following the conference. The presentation can also be accessed at http://www.cyberonics.com by clicking on the link for this webcast. Access to the webcast is not password protected.

ABOUT VNS THERAPY AND CYBERONICS

Cyberonics, Inc. (NASDAQ:CYBX) is a medical technology company with core expertise in neuromodulation. The company developed and markets the Vagus Nerve Stimulation (VNS) Therapy(TM) System, which is FDA-approved for the treatments of refractory epilepsy and treatment-resistant depression. The VNS Therapy System uses a surgically implanted medical device that delivers pulsed electrical signals to the vagus nerve. Cyberonics markets the VNS Therapy System in selected markets worldwide.

Additional information on Cyberonics, Inc. and VNS Therapy(TM) is available at http://www.cyberonics.com and http://www.vnstherapy.com.

CONTACT INFORMATION:

Greg Browne, CFO

Cyberonics, Inc.

100 Cyberonics Blvd.

Houston, TX 77058

Main: (281) 228-7262

Fax: (281) 218-9332

ir@cyberonics.com


'/>"/>
SOURCE Cyberonics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Cyberonics Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2008 Financial Results
2. Cyberonics Reports Operating Profit for Third Quarter FY08 and Announces Share Repurchase Program
3. Cyberonics Announces Conference Call to Discuss FY08 Q3 Financial Results
4. Cyberonics Licenses Obesity-Related Patents
5. Sunesis Pharmaceuticals to Present at the Collins Stewart Fourth Annual Growth Conference
6. Rigel to Present at Collins Stewart Growth Conference
7. Nu Skin Enterprises to Present at Oppenheimer Consumer Growth Conference
8. FGX International to Present at the Oppenheimer 8th Annual Consumer Growth Conference
9. SuperGen to Present at the Collins Stewart Growth Conference on July 9, 2008
10. ExonHit Presents Therapeutic and Diagnostic Programs for Alzheimers at ICAD 2008
11. OptiNose presents data on highly effective migraine treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... ... April 21, 2017 , ... The staff at Palm Beach Face is proud to ... in the 2017 London Marathon. Set to take place on April 23rd, the London Marathon ... Dr. Schwartz will run as part of team EMPOWER, raising money for the international charity, ...
(Date:4/21/2017)... Pittsburgh, PA (PRWEB) , ... April 21, 2017 ... ... consultation firm in Allegheny County that offers services to communities throughout the greater ... organization in a charity drive to provide adaptive bicycles for differently-abled children. , ...
(Date:4/21/2017)... (PRWEB) , ... April 21, 2017 , ... The Hong ... the first 3D printing facility among higher education institutions in Hong Kong to support ... in terms of the range and quantity of facilities in Hong Kong. , ...
(Date:4/21/2017)... Rosa, CA (PRWEB) , ... April 21, 2017 ... ... St. Joseph Health held the much anticipated Regional Primary Care Spring Symposium on ... role in the local medical community, offering physicians and healthcare providers an opportunity ...
(Date:4/21/2017)... (PRWEB) , ... April 21, 2017 , ... Westside ... experienced, personalized dental care since 1985. After thirty-two years, Dr. Latner has become one ... to help my numerous clients over the years with all their dental needs,” said ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017 The ... Application, Forecast to 2022 report has covered and analysed the ... and information on market size, shares and growth factors. The ... drivers, challenges and opportunities in the global market. ... Browse 152 Tables and Figures, 6 ...
(Date:4/19/2017)... , April 19, 2017  New research provides evidence ... advanced Parkinson,s, according to a study released today that will ... Annual Meeting in Boston , April ... to the treatment of Parkinson,s disease, the oral drug levodopa ... life and longevity. But as the disease progresses, the effects ...
(Date:4/18/2017)... Ohio , April 18, 2017  Cardinal Health ... Non-GAAP 1 fiscal 2017 earnings per share (EPS) ... and 2019.  This is in conjunction with this morning,s ... Deep Vein Thrombosis and Nutritional Insufficiency businesses. ... from continuing operations will be at the bottom of ...
Breaking Medicine Technology: